Last reviewed · How we verify
Influenza Virus Vaccine Live, Intranasal
Influenza Virus Vaccine Live, Intranasal is a Biologic drug developed by Tufts Medical Center. It is currently in Phase 1 development. Also known as: FluMist.
At a glance
| Generic name | Influenza Virus Vaccine Live, Intranasal |
|---|---|
| Also known as | FluMist |
| Sponsor | Tufts Medical Center |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A/Texas Flu Challenge (PHASE1)
- Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection (PHASE4)
- Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection (PHASE1)
- Intranasal LAIV Mucosal Immunity Examination (PHASE4)
- Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine (PHASE4)
- Characterizing the Human Airway Immune Response to FluMist Vaccination (PHASE4)
- Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine (PHASE1)
- GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Influenza Virus Vaccine Live, Intranasal CI brief — competitive landscape report
- Influenza Virus Vaccine Live, Intranasal updates RSS · CI watch RSS
- Tufts Medical Center portfolio CI
Frequently asked questions about Influenza Virus Vaccine Live, Intranasal
What is Influenza Virus Vaccine Live, Intranasal?
Influenza Virus Vaccine Live, Intranasal is a Biologic drug developed by Tufts Medical Center.
Who makes Influenza Virus Vaccine Live, Intranasal?
Influenza Virus Vaccine Live, Intranasal is developed by Tufts Medical Center (see full Tufts Medical Center pipeline at /company/tufts-medical-center).
Is Influenza Virus Vaccine Live, Intranasal also known as anything else?
Influenza Virus Vaccine Live, Intranasal is also known as FluMist.
What development phase is Influenza Virus Vaccine Live, Intranasal in?
Influenza Virus Vaccine Live, Intranasal is in Phase 1.
Related
- Manufacturer: Tufts Medical Center — full pipeline
- Also known as: FluMist
- Compare: Influenza Virus Vaccine Live, Intranasal vs similar drugs
- Pricing: Influenza Virus Vaccine Live, Intranasal cost, discount & access